Sematid Tablet 7 mg contains Semaglutide, an oral GLP-1 receptor agonist indicated for the management of type 2 diabetes mellitus in adults. It is designed to improve glycemic control when used alongside proper diet and regular physical activity. The 7 mg strength is generally prescribed as a maintenance dose after initial treatment with the lower starting dose, depending on the patient’s response and tolerability.

Semaglutide works by mimicking the natural incretin hormone GLP-1 (glucagon-like peptide-1). It enhances glucose-dependent insulin secretion, reduces glucagon release, slows gastric emptying, and promotes a feeling of satiety. These combined effects help lower blood glucose levels and may also support gradual weight reduction in patients with type 2 diabetes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Sematid Tablet 7 mg is indicated for:

• Improvement of glycemic control in adults with type 2 diabetes mellitus

• Use as an adjunct to diet and exercise

• Patients who require additional blood sugar control despite lifestyle modification

It may be used as monotherapy or in combination with other oral antidiabetic agents or insulin, as prescribed by a healthcare professional.

Mechanism of Action

Semaglutide acts by targeting GLP-1 receptors and producing multiple beneficial effects:

• Stimulates insulin secretion when blood glucose levels are elevated

• Suppresses inappropriate glucagon secretion

• Delays gastric emptying to reduce post-meal glucose spikes

• Helps control appetite, which may aid in weight management

Because its insulin-stimulating action is glucose-dependent, the risk of hypoglycemia is lower when used alone compared to some other antidiabetic medicines.

Dosage and Administration

Sematid Tablet 7 mg is usually taken once daily. It should be taken on an empty stomach with a small amount of plain water (not more than 120 ml), at least 30 minutes before the first food, beverage, or other oral medication of the day.

Swallow the tablet whole without breaking, crushing, or chewing. The dose may be adjusted by the physician based on blood glucose control and patient response.

Precautions and Warnings

• Not indicated for type 1 diabetes or diabetic ketoacidosis.

• Use cautiously in patients with a history of pancreatitis.

• Gastrointestinal symptoms are common during dose escalation.

• Monitor blood glucose regularly as advised.

• Inform your healthcare provider about any other medications you are taking.

Pregnant or breastfeeding women should consult a doctor before starting treatment.

Side Effects

Common side effects may include:

• Nausea

• Vomiting

• Diarrhea

• Abdominal discomfort

• Reduced appetite

These effects are generally mild to moderate and tend to decrease over time. Seek medical advice if symptoms persist or become severe.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Sematid Tablet 7 mg offers an effective oral GLP-1 receptor agonist option for improving blood glucose control in adults with type 2 diabetes, supporting better long-term metabolic health when used under medical supervision.